Mirabella Financial Services LLP Has $5.89 Million Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Mirabella Financial Services LLP lessened its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 61.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 24,844 shares of the medical research company’s stock after selling 38,971 shares during the period. Mirabella Financial Services LLP’s holdings in IQVIA were worth $5,887,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Capital Performance Advisors LLP bought a new stake in shares of IQVIA during the 3rd quarter valued at $27,000. Park Place Capital Corp bought a new stake in IQVIA during the third quarter worth about $28,000. Versant Capital Management Inc increased its holdings in IQVIA by 733.3% in the 2nd quarter. Versant Capital Management Inc now owns 125 shares of the medical research company’s stock valued at $26,000 after buying an additional 110 shares during the period. Opal Wealth Advisors LLC acquired a new position in shares of IQVIA in the 2nd quarter valued at approximately $27,000. Finally, Itau Unibanco Holding S.A. bought a new stake in shares of IQVIA during the 2nd quarter worth approximately $29,000. Institutional investors and hedge funds own 89.62% of the company’s stock.

Insider Activity at IQVIA

In related news, insider Eric Sherbet sold 1,300 shares of the business’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the transaction, the insider now owns 19,536 shares in the company, valued at $4,812,302.88. The trade was a 6.24 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have commented on IQV. The Goldman Sachs Group lowered their price objective on shares of IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Barclays dropped their price objective on IQVIA from $260.00 to $255.00 and set an “overweight” rating for the company in a research report on Friday, November 1st. BTIG Research lowered their target price on IQVIA from $290.00 to $260.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Argus upgraded shares of IQVIA to a “strong-buy” rating in a research note on Wednesday, July 31st. Finally, Morgan Stanley decreased their target price on shares of IQVIA from $280.00 to $265.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Four research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, IQVIA currently has an average rating of “Moderate Buy” and an average target price of $256.50.

IQVIA Stock Performance

Shares of IQV opened at $204.45 on Monday. The firm’s fifty day simple moving average is $222.67 and its two-hundred day simple moving average is $227.16. IQVIA Holdings Inc. has a 12 month low of $187.62 and a 12 month high of $261.73. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The stock has a market capitalization of $37.11 billion, a P/E ratio of 26.49, a price-to-earnings-growth ratio of 2.08 and a beta of 1.51.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.